help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boehmer, A. L. M.
Right arrow Articles by Drop, S. L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boehmer, A. L. M.
Right arrow Articles by Drop, S. L. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 12 4713-4721
Copyright © 1999 by The Endocrine Society


Original Studies

17ß-Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations1

Annemie L. M. Boehmer, Albert O. Brinkmann, Lodewijk A. Sandkuijl, Dicky J. J. Halley, Martinus F. Niermeijer, Stefan Andersson, Frank H. de Jong, Hülya Kayserili, Monique A. de Vroede, Barto J. Otten, Catrienus W. Rouwé, Berenice B. Mendonça, Cidade Rodrigues, Hans H. Bode, Petra E. de Ruiter, Henriette A. Delemarre-van de Waal and Stenvert L. S. Drop

Division of Endocrinology, Department of Pediatrics, Sophia Children’s Hospital (A.L.M.B., S.L.S.D.), Rotterdam; Wilhelmina Children’s Hospital (M.A.V.), Utrecht; University Hospital Nijmegen (B.J.O.), Nijmegen; University Hospital Groningen (C.W.R.), Groningen; Free University Hospital Amsterdam (H.A.D.W.), Amsterdam; the Department of Endocrinology and Reproduction, Erasmus University (A.L.M.B., A.O.B., F.H.J., P.E.R.), Rotterdam; Department of Clinical Genetics, University Hospital Rotterdam and Erasmus University (A.L.M.B., L.A.S., D.J.J.H., M.F.N.), Rotterdam; the Department of Internal Medicine III, University Hospital Rotterdam (F.H.J.);, Rotterdam, The Netherlands; The Netherlands; Cecil H. and Ida Green Center for Reproductive Biological Sciences, University of Texas Southwestern Medical Center (S.A), Dallas, Texas 75235; the Division of Endocrinology, Department of Pediatrics, Medical Genetics Division, Institute of Child Health, Istanbul Medical Faculty, University of Istanbul (H.K.), Istanbul, Turkey; the Developmental Endocrinology Unit, Division of Endocrinology, Hospital das Clinicas, University of Sao Paulo (B.B.M.), Sao Paulo, Brazil; Hospital Maria Pia (C.R.), Porto, Portugal; and the Department of Pediatric Endocrinology, Sydney Children’s Hospital (H.H.B.), Randwick, Australia

Address all correspondence and requests for reprints to: Dr. Annemie L. M. Boehmer, M.D., Department of Pediatrics, Division of Endocrinology, Sophia Children’s Hospital, P.O. Box 2060, 3000 CB Rotterdam, The Netherlands. E-mail: boehmer{at}ALKG.AZR.NL

17ß-Hydroxysteroid dehydrogenase-3 (17ßHSD3) deficiency is an autosomal recessive form of male pseudohermaphroditism caused by mutations in the HSD17B3 gene. In a nationwide study on male pseudohermaphroditism among all pediatric endocrinologists and clinical geneticists in The Netherlands, 18 17ßHSD3-deficient index cases were identified, 12 of whom initially had received the tentative diagnosis androgen insensitivity syndrome (AIS). The phenotypes and genotypes of these patients were studied. Endocrine diagnostic methods were evaluated in comparison to mutation analysis of the HSD17B3 gene. RT-PCR studies were performed on testicular ribonucleic acid of patients homozygous for two different splice site mutations. The minimal incidence of 17ßHSD3 deficiency in The Netherlands and the corresponding carrier frequency were calculated. Haplotype analysis of the chromosomal region of the HSD17B3 gene in Europeans, North Americans, Latin Americans, Australians, and Arabs was used to establish whether recurrent identical mutations were ancient or had repeatedly occurred de novo.

In genotypically identical cases, phenotypic variation for external sexual development was observed. Gonadotropin-stimulated serum testosterone/androstenedione ratios in 17ßHSD3-deficient patients were discriminative in all cases and did not overlap with ratios in normal controls or with ratios in AIS patients. In all investigated patients both HSD17B3 alleles were mutated. The intronic mutations 325 + 4;A->T and 655–1;G->A disrupted normal splicing, but a small amount of wild-type messenger ribonucleic acid was still made in patients homozygous for 655–1;G->A. The minimal incidence of 17ßHSD3 deficiency in The Netherlands was shown to be 1:147,000, with a heterozygote frequency of 1:135. At least 4 mutations, 325 + 4;A->T, N74T, 655–1;G->A, and R80Q, found worldwide, appeared to be ancient and originating from genetic founders. Their dispersion could be reconstructed through historical analysis. The HSD17B3 gene mutations 326–1;G->C and P282L were de novo mutations.

17ßHSD3 deficiency can be reliably diagnosed by endocrine evaluation and mutation analysis. Phenotypic variation can occur between families with the same homozygous mutations. The incidence of 17ßHSD3 deficiency is 0.65 times the incidence of AIS, which is thought to be the most frequent known cause of male pseudohermaphroditism without dysgenic gonads. A global inventory of affected cases demonstrated the ancient origin of at least four mutations. The mutational history of this genetic locus offers views into human diversity and disease, provided by national and international collaboration.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
T S Han, D Goswami, S Trikudanathan, S M Creighton, and G S Conway
Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis
Eur. J. Endocrinol., August 1, 2008; 159(2): 179 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Bouvattier, B. Mignot, H. Lefevre, Y. Morel, and P. Bougneres
Impaired Sexual Activity in Male Adults with Partial Androgen Insensitivity
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3310 - 3315.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Rey, E. Codner, G. Iniguez, P. Bedecarras, R. Trigo, C. Okuma, S. Gottlieb, I. Bergada, S. M. Campo, and F. G. Cassorla
Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6035 - 6040.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Umar, C. A. Berrevoets, N. M. Van, M. van Leeuwen, M. Verbiest, W. J. Kleijer, D. Dooijes, J. A. Grootegoed, S. L. S. Drop, and A. O. Brinkmann
Functional Analysis of a Novel Androgen Receptor Mutation, Q902K, in an Individual with Partial Androgen Insensitivity
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. J. Migeon, A. B. Wisniewski, J. P. Gearhart, H. F.L. Meyer-Bahlburg, J. A. Rock, T. R. Brown, S. J. Casella, A. Maret, K. M. Ngai, J. Money, et al.
Ambiguous Genitalia With Perineoscrotal Hypospadias in 46,XY Individuals: Long-Term Medical, Surgical, and Psychosexual Outcome
Pediatrics, September 1, 2002; 110(3): e31 - 31.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. J. Migeon, A. B. Wisniewski, T. R. Brown, J. A. Rock, H. F. L. Meyer-Bahlburg, J. Money, and G. D. Berkovitz
46,XY Intersex Individuals: Phenotypic and Etiologic Classification, Knowledge of Condition, and Satisfaction With Knowledge in Adulthood
Pediatrics, September 1, 2002; 110(3): e32 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. M. Boehmer, H. Bruggenwirth, C. van Assendelft, B. J. Otten, M. C. T. Verleun-Mooijman, M. F. Niermeijer, H. G. Brunner, C. W. Rouwe, J. J. Waelkens, W. Oostdijk, et al.
Genotype Versus Phenotype in Families with Androgen Insensitivity Syndrome
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4151 - 4160.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. A. Hughes
Minireview: Sex Differentiation
Endocrinology, August 1, 2001; 142(8): 3281 - 3287.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Lindqvist, I. A. Hughes, and S. Andersson
Substitution Mutation C268Y Causes 17{beta}-Hydroxysteroid Dehydrogenase 3 Deficiency
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 921 - 923.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-M. Holterhus, G. H. G. Sinnecker, and O. Hiort
Phenotypic Diversity and Testosterone-Induced Normalization of Mutant L712F Androgen Receptor Function in a Kindred with Androgen Insensitivity
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3245 - 3250.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society